Singapore, May 16 -- China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensiveAI-Driven Drug Discovery (AIDD) platformto the industry.

During the event, Dr Yue Qian, Executive Director of the AIDD/CADD Platform at Viva Biotech, delivered an in-depth overview of the unique strengths of the AIDD platform, its disruptive innovations across the drug discovery process, and its three core modules-V-Scepter, V-Orb, and V-Mantle.

Through a series of case studies, Dr Qian showcased how Viva's AIDD platform acts as a transformative "enchantment" for drug R&D, offering an intelligent, efficient, and integrated approach to accelerate the discovery of novel therape...